Driven by government support and increasing demand from patients, the development of the Traditional Chinese Medicine Hospitals industry has accelerated in recent years. Industry revenue is expected to grow at an annualized 8.6% over the five years through 2022, to total $96.5 billion. This trend includes a continued return to growth, with an expected 11.3% increase in 2022, after the decline of 6.3% in 2020, partially due to the COVID-19 outbreak deterring people from visiting hospitals unless necessary.
The Traditional Chinese Medicine Hospitals industry in China comprises licensed traditional Chinese medicine general hospitals and traditional Chinese medicine specialized hospitals. Integrated traditional Chinese and Western medicine hospitals and ethnic minority hospitals are not included in this industry.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Dongzhimen Hospital
- Beijing Hospital of Traditional Chinese Medicine
- Guangdong Hospital of Traditional Chinese Medicine
- Guang'anmen Hospital
- Jiangsu Province Hospital of Traditional Chinese Medicine
Methodology
LOADING...
